چاپ صفحه |  صفحه نخست سامانه |  چکیده مقاله |  نویسندگان |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| Nowadays, a potent challenge in cancer treatment is considered the lack of efcacious strategy, which has not been able to signifcantly reduce mortality. Chemoimmunotherapy (CIT) as a promising approach in both for the frst-line and relapsed therapy demonstrated particular beneft from two key gating strategies, including chemotherapy and immunotherapy to cancer therapy; therefore, the discernment of their participation and role of potential synergies in CIT approach is determinant. In this study, in addition to balancing the pros and cons of CIT with the challenges of each of two main strategies, the recent advances in the cancer CIT have been discussed. Additionally, immunotherapeutic strategies and the immunomodulation efect induced by chemotherapy, which boosts CIT have been brought up. Finally, harnessing and development of the nanoparticles, which mediated CIT have expatiated in detail |
| نویسنده | نفر چندم مقاله |
|---|---|
| رفیعه باقری فر | اول |
| سید حسین کیایی | دوم |
| بهزاد برادران | ششم |
| یوسف جوادزاده | هشتم |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| bagerifar- review.pdf | 1400/08/04 | 1253567 | دانلود |
